Glenmede Trust CO Na Care Dx, Inc. Transaction History

Glenmede Trust CO Na

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $114,743 - $222,432	-5,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$28.19 - $46.6 $157,864 - $260,960	5,600 New	5,600 $207,000
Q4 2021 Feb 15, 2022	SELL	$41.2 - $73.6 $723,183 - $1.29 Million	-17,553 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $425,406 - $661,592	7,192 Added 69.41%	17,553 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$63.02 - $95.11 $652,950 - $985,434	10,361 New	10,361 $948,000
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $1,019 - $1,252	-33 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$18.95 - $35.43 $625 - $1,169	33 New	33 $1,000
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $84,126 - $168,336	-4,200 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$25.78 - $39.77 $22,686 - $34,997	880 Added 26.51%	4,200 $151,000
Q1 2019 May 14, 2019	BUY	$22.09 - $39.21 $53,347 - $94,692	2,415 Added 266.85%	3,320 $104,000
Q4 2018 Feb 14, 2019	BUY	$19.89 - $30.02 $18,000 - $27,168	905 New	905 $22,000

215

50.9M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.25B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.